KRMD KORU Medical Systems Inc. Cumulative Company Assets
KORU Medical Systems (KRMD) faces threats of FDA certification delays and logistical disruptions, as clearly demonstrated by the price action shown below, where total assets are fixed at 26.76. The company is mitigating these threats by releasing drug delivery devices for home use, which are in high demand among immunocompromised individuals. The development of innovative infusion systems enables the business to grow by simplifying patient care outside of hospital settings.
%20Company%20Total%20Assets&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_KRMD_-_KORU-Medical-Systems_-_Company-Total-Assets "korumedical.com (KRMD) - Company Assets from 07/04/2022 to 10/29/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for korumedical.com (KRMD)
The indicator is calculated inversely through return on assets, reflecting the dynamics of total resources and liabilities. This metric determines the business's material base, allowing for an assessment of the company's resilience to market shocks. For KORU Medical Systems (KRMD), asset volume is critical, as high R&D costs and regulatory complexities in the EU require a significant financial reserve. Analyzing the structure of total balance sheet assets helps identify the risk of a "value trap" during revenue stagnation.